Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2015-08-13 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: AULNAT (63510), Puy-de-Dome
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DEVEZ VIDAL : revenue, balance sheet and financial ratios
PHARMACIE DEVEZ VIDAL is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in AULNAT (63510),
this company of category PME
shows in 2025 a net income positive of 166 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DEVEZ VIDAL (SIREN 813040250)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
166 333 €
155 876 €
157 966 €
151 062 €
159 393 €
145 274 €
139 756 €
144 838 €
82 781 €
19 063 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DEVEZ VIDAL generates positive net income of 166 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 19 k€ -> 166 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
166 333 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 18%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 80%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
17.695%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
79.626%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
0.0
365.653
277.666
201.71
146.478
105.889
73.49
48.924
31.906
17.695
Financial autonomy
15.001
17.883
23.852
30.16
37.215
45.255
54.205
62.746
69.502
79.626
Repayment capacity
None
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
17.72025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good-13 pts over 3 years
In 2025, the debt ratio of PHARMACIE DEVEZ VIDAL (17.70) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
79.63%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Excellent+13 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DEVEZ VIDAL (79.6%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 253.41. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
240.746
113.245
206.181
231.007
245.802
275.801
278.784
241.718
215.149
253.406
Interest coverage
None
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
253.412025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good+7 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DEVEZ VIDAL (253.41) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DEVEZ VIDAL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DEVEZ VIDAL is estimated at
2 642 219 €
(range 1 793 022€ - 4 146 006€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1793k€2642k€4146k€
2 642 219 €Range: 1 793 022€ - 4 146 006€
NAF 5 année 2025
Valuation method used
Net Income Multiple
166 333 €
×
15.9x
=2 642 219 €
Range: 1 793 023€ - 4 146 006€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DEVEZ VIDAL with other companies in the same sector:
Frequently asked questions about PHARMACIE DEVEZ VIDAL
What is the revenue of PHARMACIE DEVEZ VIDAL ?
The revenue of PHARMACIE DEVEZ VIDAL is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DEVEZ VIDAL profitable?
Yes, PHARMACIE DEVEZ VIDAL generated a net profit of 166 k€ in 2025.
Where is the headquarters of PHARMACIE DEVEZ VIDAL ?
The headquarters of PHARMACIE DEVEZ VIDAL is located in AULNAT (63510), in the department Puy-de-Dome.
Where to find the tax return of PHARMACIE DEVEZ VIDAL ?
The tax return of PHARMACIE DEVEZ VIDAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DEVEZ VIDAL operate?
PHARMACIE DEVEZ VIDAL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart